Cerity Partners LLC Acquires 6,167 Shares of ResMed Inc. (NYSE:RMD)
Cerity Partners LLC increased its stake in ResMed Inc. (NYSE:RMD – Free Report) by 82.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The ...
Is ResMed Inc.'s (NYSE:RMD) Recent Performance Tethered To Its Attractive Financial Prospects?
Most readers would already know that ResMed's (NYSE:RMD) stock increased by 2.6% over the past month. Since the ...
Insider Activity: Resmed Inc Director’s Share Sales
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...
Insider Transaction: Michael J Farrell Sells $499K Worth Of ResMed Shares
It was reported on November 27, that Michael J Farrell, Chief Executive Officer at ResMed RMD executed a significant insider ...
Insider Activity Spotlight: Michael J Farrell Acquires In ResMed Stock Options
What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Farrell, Chief Executive Officer at ResMed, acquired stock options for 33,036 shares of RMD. These ...
Fisher & Paykel’s Long-Term Trajectory Is Intact
Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...
ResMed CEO’s Stock Transactions and Options Activity
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...
ResMed Inc. stock falls Wednesday, still outperforms market
Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...
stockhead4d
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
The maker of anti-snoring mouthguards, Somnomed has upgraded full-yearguidance and investors are awake to the opportunity.
Downgrading ResMed Inc. Because It's Doing Well
ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...
EurekAlert!5d
Irregular sleep-wake cycle linked to heightened risk of major cardiovascular events
An irregular sleep-wake cycle is associated with a heightened risk of major cardiovascular events, such as heart attack and stroke, even for those who clock up the recommended nightly hours of ...
ResMed: Solid Execution, Pricey Valuation
Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...